1 |
Honig MG, Del Mar NA, Moore BM, Reiner A. Raloxifene Mitigates Emotional Deficits after Mild Traumatic Brain Injury in Mice. Neurotrauma Reports 2022;3:534-544. [DOI: 10.1089/neur.2022.0052] [Reference Citation Analysis]
|
2 |
Boucher ML, Conley G, Nowlin J, Qiu J, Kawata K, Bazarian JJ, Meehan WP, Mannix R. Titrating the Translational Relevance of a Low-Level Repetitive Head Impact Model. Front Neurol 2022;13:857654. [DOI: 10.3389/fneur.2022.857654] [Reference Citation Analysis]
|
3 |
Martini DN, Gera G, Brumbach BH, Campbell KR, Parrington L, Chesnutt J, King LA. Symptoms and Central Sensory Integration in People With Chronic mTBI: Clinical Implications. Mil Med 2022:usac157. [PMID: 35657326 DOI: 10.1093/milmed/usac157] [Reference Citation Analysis]
|
4 |
Honig MG, Del Mar NA, Henderson DL, O'Neal D, Yammanur M, Cox R, Li C, Perry AM, Moore BM, Reiner A. Raloxifene, a cannabinoid type-2 receptor inverse agonist, mitigates visual deficits and pathology and modulates microglia after ocular blast. Exp Eye Res 2022;:108966. [PMID: 35143834 DOI: 10.1016/j.exer.2022.108966] [Reference Citation Analysis]
|
5 |
Honig MG, Del Mar NA, Henderson DL, O'Neal D, Doty JB, Cox R, Li C, Perry AM, Moore BM, Reiner A. Raloxifene Modulates Microglia and Rescues Visual Deficits and Pathology After Impact Traumatic Brain Injury. Front Neurosci 2021;15:701317. [PMID: 34776838 DOI: 10.3389/fnins.2021.701317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
6 |
Abd-El-Basset EM, Rao MS, Alsaqobi A. Interferon-Gamma and Interleukin-1Beta Enhance the Secretion of Brain-Derived Neurotrophic Factor and Promotes the Survival of Cortical Neurons in Brain Injury. Neurosci Insights 2020;15:2633105520947081. [PMID: 32776009 DOI: 10.1177/2633105520947081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|